VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 75 filers reported holding VAXCYTE INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $54,944,000 | -6.2% | 2,309,554 | 0.0% | 4.23% | -9.8% |
| Q3 2021 | $58,593,000 | +12.7% | 2,309,554 | 0.0% | 4.69% | -2.2% |
| Q2 2021 | $51,988,000 | +14.0% | 2,309,554 | 0.0% | 4.79% | +31.0% |
| Q1 2021 | $45,614,000 | -25.7% | 2,309,554 | 0.0% | 3.66% | -22.6% |
| Q4 2020 | $61,365,000 | -46.2% | 2,309,554 | 0.0% | 4.73% | -53.8% |
| Q3 2020 | $114,046,000 | +56.2% | 2,309,554 | 0.0% | 10.24% | +59.7% |
| Q2 2020 | $73,005,000 | – | 2,309,554 | – | 6.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $90,711,000 | 29.04% |
| Medicxi Ventures Management (Jersey) Ltd | 3,774,956 | $82,142,000 | 17.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 832,166 | $18,108,000 | 9.12% |
| GREAT POINT PARTNERS LLC | 985,153 | $21,437,000 | 5.14% |
| Kynam Capital Management, LP | 723,781 | $15,749,000 | 4.02% |
| Ghost Tree Capital, LLC | 325,000 | $7,072,000 | 3.68% |
| Frazier Life Sciences Management, L.P. | 1,787,405 | $38,894,000 | 3.67% |
| RA Capital Management | 4,581,203 | $99,687,000 | 2.66% |
| Opaleye Management Inc. | 190,000 | $4,134,000 | 1.86% |
| Soleus Capital Management, L.P. | 370,650 | $8,065,000 | 1.26% |